Endocrine Society members elected Nanette Santoro, MD (left) of the University of Colorado School of Medicine in Aurora, Colo., as its 2026-2027 President. She will serve as President-Elect for a year beginning in July 2025 before becoming President in June 2026. Santoro has served as E. Stewart Taylor Chair of Obstetrics & Gynecology at the...
ENDO 2025 in San Francisco: Vast Opportunities for Attendees to Learn and Network
The Endocrine Society offers many things to our thousands of members: continuing education, clinical guidelines, scientific statements, advocacy campaigns, networking groups, career development, awards recognition, and leadership opportunities, to name a few. But the Society’s biggest and most visible offering by far is ENDO! This year’s ENDO 2025 in San Francisco, Calif., July 12-15, promises...Kids On the Move: Protecting Future Generations from Obesity
Leading pediatric endocrinologist and recipient of the Endocrine Society’s 2025 Outstanding Leadership in Endocrinology Laureate Award, Ilene Fennoy, MD, talks with Endocrine News about the potential of GLP-1s and long-term solutions for childhood obesity. She says a good place to start is creating more programs in schools to help kids eat better and incorporate more...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Celltrion Receives U.S. FDA Approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) Biosimilars Referencing PROLIA® and XGEVA® On March 3, Celltrion announced that the U.S. Food and Drug Administration (FDA) has approved STOBOCLO® (CT-P41, denosumab-bmwo) and OSENVELT® (CT-P41, denosumab-bmwo), biosimilars referencing PROLIA® (denosumab) and XGEVA® (denosumab) respectively...
Weighing In: Making Obesity Treatment More Effective and Accessible by 2030
Endocrine News speaks to the participants of the ENDO 2025 symposium “Future Developments and Challenges in Obesity Treatment: Where Will We Stand at ENDO 2030?” who discuss the future of treating this formidable condition. This July, the year’s biggest event in endocrinology happens in San Francisco, Calif. Although every ENDO is special, ENDO 2025...
As February gets underway, Endocrine News is taking this opportunity to commemorate Black History Month with a roundtable that features some of the Endocrine Society’s outstanding Black members who have made remarkable contributions to not only the Society, but to the field of endocrinology (“Lift Every Voice”). These five members were very generous with their...Harsh Realities: How Treating Obesity Across the Lifespan Continues to Evolve
Fatima Cody Stanford, MD, MPH, MPA, MBA, takes the lessons she learned growing up in Atlanta serving her community and applies them to her work treating obesity. In July, she’ll give the plenary presentation at ENDO 2025, “Changing the Game of Obesity Care Across Lifespan: Policies, Diets, and Drug Innovation,” offering attendees a comprehensive overview...
Endocrine Society member Tina Gupta, MD, spent many years managing her patients’ type 1 diabetes when she was in a clinical setting. Now that she’s associate medical director on the Type 1 Diabetes Medical Affairs team at Vertex Pharmaceuticals, she’s even more determined to help find solutions to help these patients. As an endocrinologist, my...
